Identification of a Novel Subtype of Ocular Hypertensive Eyes with the Lowest Risk of Progression Under Treatment
We identified a subtype of ocular hypertensive eyes in the OHTS that showed a better response to topical hypotensive medications, as indicated by the least risk of progression.
Authors
- Louis R. Pasquale (ORCID: https://orcid.org/0000-0002-5835-3496)
- Michael V. Boland (ORCID: https://orcid.org/0000-0003-2506-7095)
- Chris A. Johnson (ORCID: https://orcid.org/0000-0002-0090-630X)
- Siamak Yousefi (ORCID: https://orcid.org/0000-0001-8633-5730)
- Asma Poursoroush
- Anne Curry (ORCID: https://orcid.org/0000-0002-7677-5561)
- Vida Abedi (ORCID: https://orcid.org/0000-0001-7689-933X)
- Alireza Vafaei Sadr (ORCID: https://orcid.org/0000-0002-5733-6678)
- Jiang Li (ORCID: https://orcid.org/0000-0002-7006-1285)
- Xiaoqin Huang
Institutions
- Massachusetts Eye and Ear Infirmary (US)
- Pennsylvania State University (US)
- Harvard University (US)
- University of Tennessee Health Science Center (US)
- University of Iowa Hospitals and Clinics (US)
- Universitätsklinikum Aachen (DE)
- Geisinger Health System (US)
- RWTH Aachen University (DE)
- University of Memphis (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Ophthalmology and Therapy
- Published
- 2025-06-28
- DOI
- https://doi.org/10.1007/s40123-025-01174-3
- Primary Topic
- Glaucoma and retinal disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health